[Vaginal estradiol and progesterone in climacteric therapy]

Area of Science:

• Endocrinology
• Pharmacology
• Gynecology

Background:

• Menopause is associated with estrogen and progesterone deficiency, leading to various symptoms.
• Hormone replacement therapy (HRT) is a common treatment for menopausal symptoms.
• Vaginal administration offers localized delivery and potentially reduced systemic side effects.

Purpose of the Study:

• To evaluate the absorption and efficacy of vaginal suppositories containing micronized estradiol and progesterone in postmenopausal women.
• To assess the impact of these suppositories on menopausal symptoms, serum lipids, and vaginal bleeding.

Main Methods:

• Seven postmenopausal women had pharmacokinetics of estradiol and progesterone suppositories measured over 24 hours.
• Ten postmenopausal women received daily suppositories for three months to assess symptom relief.
• Serum lipid concentrations and vaginal bleeding patterns were monitored.

Main Results:

• Peak serum concentrations of estradiol and progesterone were achieved within six hours.
• Daily suppository use for three months significantly reduced vasomotor, mental, and urogenital menopausal symptoms.
• No significant changes in serum lipid levels were observed; minimal vaginal bleeding occurred in most patients.

Conclusions:

• Vaginal suppositories with estradiol and progesterone demonstrate favorable absorption and clinical efficacy in managing menopausal symptoms.
• The treatment appears safe regarding serum lipids and vaginal bleeding, although endometrial effects require further study.
• This formulation offers a promising therapeutic option for postmenopausal symptom management.